newsfilter
← Latest News
ACCESS Newswire·

Aspire Biopharma Holdings, Inc. Announces the Execution of Securities Purchase Agreement

NEW YORK CITY, NY / ACCESS Newswire / February 20, 2025 / Aspire Biopharma, Inc. , a developer of a multi-faceted patent-protected disruptive drug delivery mechanism